e-learning
resources
2020
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Population-based survey of antimycobacterial drug use among patients with non-tuberculosis mycobacterial pulmonary disease
Kiyohiko Izumi, Kozo Morimoto, Kazuhiro Uchimura, Manabu Ato, Naoki Hasegawa, Satoshi Mitarai
Source:
ERJ Open Res, 6 (1) 00097-2019; 10.1183/23120541.00097-2019
Journal Issue:
January
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Kiyohiko Izumi, Kozo Morimoto, Kazuhiro Uchimura, Manabu Ato, Naoki Hasegawa, Satoshi Mitarai. Population-based survey of antimycobacterial drug use among patients with non-tuberculosis mycobacterial pulmonary disease. ERJ Open Res, 6 (1) 00097-2019; 10.1183/23120541.00097-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Monitoring of drug resistance of TB mycobacteria in new pulmonary TB patients
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
The impact of different antibiotic treatment regimens on mortality in
Mycobacterium avium
complex pulmonary disease: a population-based cohort study
Source: Eur Respir J, 56 (3) 1901875; 10.1183/13993003.01875-2019
Year: 2020
Aero-environmental bacteriological survey of respiratory non-tuberculosis mycobacterial disease patients
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016
Epidemiological features of nosocomial tuberculosis in patients with pulmonary tuberculosis in TB hospital
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018
Comparative study of clinical features between elderly and non-elderly patients with pulmonary nontuberculous mycobacterial disease
Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis
Year: 2021
The prevalence and clinical profile of non-tuberculous mycobacterial pulmonary infection in Singapore
Source: International Congress 2018 – Respiratory epidemiology: from infectious diseases to lung cancer
Year: 2018
Pulmonary diseases due to non-tuberculous mycobacteria in TB referral clinical center
Source: Annual Congress 2011 - Clinical challenges in tuberculosis
Year: 2011
Efficacy of isoniazid preventive therapy for latent tuberculosis infection in patients with immune-mediated inflammatory disorders-a retrospective cohort study in Taiwan
Source: International Congress 2017 – Migrants and screening
Year: 2017
Limitations of immune-based diagnostics in patients suspected for pulmonary tuberculosis
Source: Annual Congress 2009 - Frontiers in the diagnosis of tuberculosis
Year: 2009
Clinical efficacy of new anti-TB drug ²tubelon² during complex chemotherapy in patients with first-time diagnosed destuctive pulmonary TB
Source: Eur Respir J 2006; 28: Suppl. 50, 8s
Year: 2006
Study of molecular-genetic mutations of tuberculosis mycobacteria in patients with pulmonary TB in Azerbaijan
Source: International Congress 2018 – Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity
Year: 2018
Preliminary validation of the NTM Module: a patient-reported outcome measure for patients with pulmonary nontuberculous mycobacterial disease
Source: Eur Respir J, 55 (1) 1901300; 10.1183/13993003.01300-2019
Year: 2020
Clinical characteristics and treatment outcomes of patients with macrolide-resistant Mycobacterium avium complex pulmonary disease: a systemic review and meta-analysis
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019
The radiological spectrum of pulmonary multidrug-resistant tuberculosis in HIV-negative patients
Source: Eur Respir J 2005; 26: Suppl. 49, 652s
Year: 2005
The radiological spectrum of pulmonary multidrug-resistant tuberculosis in HIV-negative patients
Source: Eur Respir J 2006; 28: Suppl. 50, 13s
Year: 2006
The radiological spectrum of pulmonary multidrug-resistant tuberculosis in HIV-negative patients
Source: Annual Congress 2008 - Imaging of different lung diseases: clinical and experimental observations
Year: 2008
Primary drug resistance of mycobacterium tuberculosis in HIV-positive patients
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016
New guidelines for treatment of nontuberculous mycobacterial pulmonary disease
Source: Virtual Congress 2020 – German programme 2020
Year: 2020
Long-term follow-up study of patients with pneumoconiosis complicated by nontuberculous mycobacterial lung disease: report of four cases
Source: Eur Respir J 2001; 18: Suppl. 33, 443s
Year: 2001
When is an infectious disease? The clinical spectrum of nontuberculous mycobacterial pulmonary disease
Source: International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept